“Nothing to do with geopolitics”: WuXi Biologics CEO bullish in …
Jan 16, 2025 · Premium News. Earnings. Tech. Housing. Crypto. ... WuXi Vaccines, will sell its vaccine manufacturing facility in Dundalk, Ireland to Merck & Co. for approximately $500m, the company announced ...
Drug giant MSD buys Wuxi’s Irish vaccines plant in €500m deal
Jan 6, 2025 · Pharma giant MSD is buying the Dundalk-based vaccines plant of Chinese rival Wuxi in a €500 million deal. Wuxi invested €200 million in 2019 to build the plant, which currently employs 200...
Pharmaceutical Technology
Jan 7, 2025 · WuXi Biologics subsidiary WuXi Vaccines has agreed to sell its vaccine manufacturing facility in Dundalk, Ireland, to MSD for approximately $500m. Expected to close in the first half of 2025, the deal follows a series of moves by WuXi Biologics to sell off sites in the US and Europe as the prospect of the Biosecure Act is deterring potential ...
WuXi Biologics Sells Irish Vaccine Site to Merck for $500m
Jan 7, 2025 · WuXi Biologics has announced the sale of its Dundalk, Ireland-based vaccine manufacturing facility to Merck for US$500 million. This news comes shortly after its parent company, WuXi AppTec, revealed plans to reduce its operational footprint.
MSD Ireland in deal to buy WuXi Vaccines' Dundalk site - RTÉ
Jan 6, 2025 · Pharmaceutical firm MSD has agreed a deal to buy the WuXi Vaccines manufacturing facility in Dundalk, Co Louth as part of its long-term plans in Ireland. MSD said the deal is worth €500m and...
Merck Snaps Up WuXi Biologics Facility in Ireland for $500M
Jan 6, 2025 · Facing increasing global pressure, WuXi Biologics will sell its Ireland vaccines facility to Merck for $500 million. The two companies have been collaborating on the Dundalk site since 2019, when WuXi agreed to build the vaccine manufacturing facility.
MSD Ireland takeover of WuXi plant ‘a tremendous vote of …
Jan 6, 2025 · Healthcare company MSD Ireland has acquired the state-of -the art WuXoi manufacturing plant in Dundalk, with the official handover expecting to take place during the first half of 2025.
MSD buy out WuXi Vaccines’ Dundalk plant in €500m deal
Jan 6, 2025 · The pharmaceutical firm MSD is buying out the WuXi Vaccines manufacturing plant in Dundalk, in a €500m deal. The American company says that in addition to the 150 jobs at the Dundalk...
MSD Ireland to Acquire WuXi Vaccines' Dundalk Facility
Jan 6, 2025 · MSD invests over €500 million in acquiring WuXi Vaccines' Dundalk site. The handover process is expected to complete by the first half of 2025. The acquisition will add approximately 1,000 jobs across Ireland. The Dundalk facility includes drug substance and product manufacturing.
WuXi ‘considering selling its Dundalk plant’: report
Oct 4, 2024 · WuXi Biologics, which has a major manufacturing facility outside Dundalk, is considering selling some of its European production facilities, according to a report in the Financial Times.
- Some results have been removed